Freestone Capital Holdings LLC Sells 365 Shares of Cardinal Health, Inc. (NYSE:CAH)

Freestone Capital Holdings LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 0.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,644 shares of the company’s stock after selling 365 shares during the period. Freestone Capital Holdings LLC’s holdings in Cardinal Health were worth $6,581,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CAH. Mirae Asset Global Investments Co. Ltd. increased its holdings in Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock worth $3,871,000 after purchasing an additional 8,471 shares in the last quarter. CHURCHILL MANAGEMENT Corp boosted its stake in shares of Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock worth $28,435,000 after buying an additional 3,576 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after buying an additional 42,082 shares during the last quarter. Consolidated Planning Corp boosted its stake in shares of Cardinal Health by 40.0% in the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock worth $1,056,000 after buying an additional 2,552 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Cardinal Health by 2.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after buying an additional 33,388 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Jefferies Financial Group upgraded Cardinal Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. JPMorgan Chase & Co. boosted their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Wells Fargo & Company upped their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Finally, Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $139.36.

Cardinal Health Price Performance

Shares of CAH stock opened at $127.50 on Thursday. The company’s fifty day simple moving average is $125.28 and its two-hundred day simple moving average is $118.57. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The stock has a market capitalization of $30.80 billion, a price-to-earnings ratio of 23.79, a PEG ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. Cardinal Health’s payout ratio is currently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.